Aveo Capital Partners’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,976
| Closed | -$661K | – | 201 |
|
|
2019
Q2 | $661K | Buy |
7,976
+7,544
| +1,746% | +$625K | 0.29% | 76 |
|
|
2019
Q1 | $35K | Hold |
432
| – | – | 0.02% | 166 |
|
|
2018
Q4 | $31K | Hold |
432
| – | – | 0.02% | 129 |
|
|
2018
Q3 | $58K | Hold |
432
| – | – | 0.03% | 138 |
|
|
2018
Q2 | $52K | Hold |
432
| – | – | 0.02% | 138 |
|
|
2018
Q1 | $47K | Hold |
432
| – | – | 0.02% | 140 |
|
|
2017
Q4 | $126K | Hold |
432
| – | – | 0.04% | 139 |
|
|
2017
Q3 | $107K | Sell |
432
-2
| -0.5% | -$495 | 0.04% | 131 |
|
|
2017
Q2 | $225K | Buy |
434
+210
| +94% | +$109K | 0.08% | 109 |
|
|
2017
Q1 | $123K | Sell |
224
-849
| -79% | -$466K | 0.05% | 124 |
|
|
2016
Q4 | $661K | Buy |
+1,073
| New | +$661K | 0.19% | 82 |
|